APA Citation

Eilers, G., Czaplinski, J. T., Mayeda, M., Bahri, N., Tao, D., Zhu, M., . . . Mariño-Enriquez, A. (2015). CDKN2A/p16 loss implicates CDK4 as a therapeutic target in imatinib-resistant dermatofibrosarcoma protuberans. Mol Cancer Ther.

Citação norma Chicago

Eilers, Grant, et al. "CDKN2A/p16 Loss Implicates CDK4 As a Therapeutic Target in Imatinib-resistant Dermatofibrosarcoma Protuberans." Mol Cancer Ther 2015.

MLA Citation

Eilers, Grant, et al. "CDKN2A/p16 Loss Implicates CDK4 As a Therapeutic Target in Imatinib-resistant Dermatofibrosarcoma Protuberans." Mol Cancer Ther 2015.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.